EFAI ChestSuite XR Pneumothorax Assessment System— 510(k) K221552

Name: FDA 510(k) clearance K221552
Creator: U.S. Food and Drug Administration
Published: 2022-11-08

Substantially Equivalent

Ever Fortune.Ai, Co., Ltd.

FDA 510(k) clearance K221552 for EFAI ChestSuite XR Pneumothorax Assessment System, Substantially Equivalent on 2022-11-08. Applicant: Ever Fortune.Ai, Co., Ltd.. Device class: 2.

Clearance details

Applicant: Ever Fortune.Ai, Co., Ltd.
Product code: Code QFM
Device class: Class 2
Regulation: 21 CFR 892.2080
Advisory panel: Radiology
Date received: 2022-05-31
Decision date: 2022-11-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Taichung City, TW

Download summary PDF View on FDA.gov ↗

Recent devices under product code QFM

view all

K253751 — CXRDetectAI2026-07-08
K252954 — MammoSightAI2026-05-04
K252482 — CogNet AI-MT+2025-12-11
K250831 — Annalise Enterprise2025-04-23
K243808 — Rayvolve PTX-PE2025-03-21

More clearances from Ever Fortune.Ai, Co., Ltd.

view all

K253163 — EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM (APPEN-CT-100)2026-04-22
K251306 — Seg Pro V3 (RT-300)2026-01-28
K242821 — EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100)2025-02-20
K241923 — EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100)2024-12-06
K234042 — EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)2024-06-07

Data sourced from openFDA. This site is unofficial and independent of the FDA.